Literature DB >> 26247792

Incidence, prevalence and outcome of rheumatic heart disease in South Africa: a systematic review of contemporary studies.

Liesl J Zühlke1, Mark E Engel2, David Watkins3, Bongani M Mayosi1.   

Abstract

BACKGROUND: Twenty years after its first democratic election, South Africa is experiencing a health transition. The impact of change on the incidence, prevalence and outcome of rheumatic heart disease (RHD) is unknown.
METHODS: We conducted a systematic overview of the incidence, prevalence and outcomes of RHD in South Africa over the past two decades according to a published protocol.
RESULTS: The overall crude incidence of symptomatic RHD was 24.7 per 100,000 (95% confidence interval (CI) 22.1 to 27.4) population per annum among adults (>13years) in Soweto, while the prevalence of asymptomatic echocardiographic RHD in schoolchildren was 20.2 cases per 1000 children (95% CI 15.3 to 26.2) in Cape Town. The 60-day mortality after admission with acute heart failure due to RHD was 24.8% (95% CI 13.6% to 42.5%) and 180-day mortality was 35.4% (95% CI 21.6% to 54.4%). Postoperative mortality at 30days was 2% (95% CI 0.0% to 4%). Post-surgical survival was over 75% at 5years, and over 70% at 10years. Cause-specific mortality rate per 100,000 population decreased from 1.27 (95% CI 1.17 to 1.39) in 1997 to 0.7 (95% CI 0.63 to 0.78) in 2012.
CONCLUSIONS: The incidence of symptomatic RHD in adults and prevalence of asymptomatic RHD in schoolchildren are high in South Africa. Mortality was high in patients with RHD-related heart failure, although post-surgical morbidity and mortality were low. Mortality attributed to RHD may be falling at a population level.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Incidence; Mortality; Prevalence; Rheumatic heart disease

Mesh:

Year:  2015        PMID: 26247792     DOI: 10.1016/j.ijcard.2015.06.145

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  19 in total

1.  Screening-detected rheumatic heart disease can progress to severe disease.

Authors:  Daniel Engelman; Gavin R Wheaton; Reapi L Mataika; Joseph H Kado; Samantha M Colquhoun; Bo Remenyi; Andrew C Steer
Journal:  Heart Asia       Date:  2016-11-28

Review 2.  Cardiovascular disease in Africa: epidemiological profile and challenges.

Authors:  Ashley K Keates; Ana O Mocumbi; Mpiko Ntsekhe; Karen Sliwa; Simon Stewart
Journal:  Nat Rev Cardiol       Date:  2017-02-23       Impact factor: 32.419

Review 3.  Mechanistic implications of altered protein expression in rheumatic heart disease.

Authors:  Evelyn N Lumngwena; Sebastian Skatulla; Jonathan M Blackburn; Ntobeko A B Ntusi
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

4.  Patterns, outcomes and trends in hospital visits of un-operated and operated children with rheumatic heart disease in Sudan.

Authors:  Sulafa Ali; Noha Karadawi; Nezar B Elhassan; Amal Ahmed M Ahmed; Maha Boctor; Heitham Awadalla; Mohamed H Ahmed
Journal:  Cardiovasc Diagn Ther       Date:  2019-04

5.  Effect of mitral valve replacement on left ventricular function in subjects with severe rheumatic mitral regurgitation.

Authors:  Sharen Maharaj; Somalingum Ponnusamy; Datshana Naidoo
Journal:  Cardiovasc J Afr       Date:  2021-02-12       Impact factor: 1.167

Review 6.  The Pan-African Society of Cardiology position paper on reproductive healthcare for women with rheumatic heart disease.

Authors:  Ana Olga Mocumbi; Keila K Jamal; Amam Mbakwem; Maylene Shung-King; Karen Sliwa
Journal:  Cardiovasc J Afr       Date:  2018-09-18       Impact factor: 0.802

7.  Rheumatic Heart Disease-Attributable Mortality at Ages 5-69 Years in Fiji: A Five-Year, National, Population-Based Record-Linkage Cohort Study.

Authors:  Tom Parks; Joseph Kado; Anne E Miller; Brenton Ward; Rachel Heenan; Samantha M Colquhoun; Till W Bärnighausen; Mariana Mirabel; David E Bloom; Robin L Bailey; Isimeli N Tukana; Andrew C Steer
Journal:  PLoS Negl Trop Dis       Date:  2015-09-15

8.  A Cost-Effectiveness Tool to Guide the Prioritization of Interventions for Rheumatic Fever and Rheumatic Heart Disease Control in African Nations.

Authors:  David Watkins; Solomon J Lubinga; Bongani Mayosi; Joseph B Babigumira
Journal:  PLoS Negl Trop Dis       Date:  2016-08-11

Review 9.  Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations.

Authors:  Liesl J Zühlke; Andrea Beaton; Mark E Engel; Christopher T Hugo-Hamman; Ganesan Karthikeyan; Judith M Katzenellenbogen; Ntobeko Ntusi; Anna P Ralph; Anita Saxena; Pierre R Smeesters; David Watkins; Peter Zilla; Jonathan Carapetis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-02

10.  The spectrum of rheumatic mitral valve regurgitation presenting to Inkosi Albert Luthuli Central Hospital, KwaZulu-Natal, over a 10-year period.

Authors:  Nomthandazo Lynn Zwane; Somalingum Ponnusamy; Datshana Prakesh Naidoo
Journal:  Cardiovasc J Afr       Date:  2021-03-16       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.